Evidence map›Paper›PMID 26575627›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Evolutionary origins of hepatitis A virus in small mammals.

Jan Felix Drexler, Victor M Corman, Alexander N Lukashev, Judith M A van den Brand, Anatoly P Gmyl, Sebastian Brünink, Andrea Rasche, Nicole Seggewiβ, Hui Feng, Lonneke M Leijten and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Over time analysis of the codon usage of SARS-CoV-2 and its variants.Computational and structural biotechnology journal · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Jan Felix DrexlerInstitute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, Bonn-Cologne, Germany; drexler@virology-bonn.de.
Victor M CormanInstitute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, Bonn-Cologne, Germany;
Alexander N LukashevChumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782, Russia;
Judith M A van den BrandDepartment of Viroscience, Erasmus MC, 3000 CA, Rotterdam, The Netherlands;
Anatoly P GmylChumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow 142782, Russia; Lomonosov Moscow State University, Moscow 119991, Russia;
Sebastian BrüninkInstitute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany;
Andrea RascheInstitute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany;
Nicole SeggewiβLaboratory of Virus Research, University of Bremen, 28359 Bremen, Germany;
Hui FengLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7292;
Lonneke M LeijtenDepartment of Viroscience, Erasmus MC, 3000 CA, Rotterdam, The Netherlands;
Peter ValloInstitute of Evolutionary Ecology and Conservation Genomics, University of Ulm, 89069 Ulm, Germany;
Thijs KuikenDepartment of Viroscience, Erasmus MC, 3000 CA, Rotterdam, The Netherlands;
Andreas DotzauerLaboratory of Virus Research, University of Bremen, 28359 Bremen, Germany;
Rainer G UlrichFriedrich-Loeffler-Institut, Institute for Novel and Emerging Infectious Diseases, 17493 Greifswald-Insel Riems, Germany.
Stanley M LemonLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7292;
Christian DrostenInstitute of Virology, University of Bonn Medical Centre, 53127 Bonn, Germany; German Centre for Infection Research, Bonn-Cologne, Germany;
Hepatovirus Ecology Consortium
Friedrich-Loeffler-Institut · DEUniversity of Bonn · DEChumakov Institute of Poliomyelitis and Viral Encephalitides · RUErasmus MC · NLGerman Center for Infection Research · DEUniversity of Bremen · DEUniversity of North Carolina at Chapel Hill · USErasmus University Rotterdam · NLScripps Research Institute · USUniversität Ulm · DE

Funding

Proteomics Pathway DiscoveryU19AI109965 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2014 to 2018
$14.9M
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped HepatovirusR01AI103083 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2012 to 2021
$4.0M
NIAID NIH HHS R01 AI103083NIAID NIH HHS R01-AI103083NIAID NIH HHS U19 AI109965NIAID NIH HHS U19-AI109965
6 · The paper itself

Abstract

Hepatitis A virus (HAV) is an ancient and ubiquitous human pathogen recovered previously only from primates. The sole species of the genus Hepatovirus, existing in both enveloped and nonenveloped forms, and with a capsid structure intermediate between that of insect viruses and mammalian picornaviruses, HAV is enigmatic in its origins. We conducted a targeted search for hepatoviruses in 15,987 specimens collected from 209 small mammal species globally and discovered highly diversified viruses in bats, rodents, hedgehogs, and shrews, which by pairwise sequence distance comprise 13 novel Hepatovirus species. Near-complete genomes from nine of these species show conservation of unique hepatovirus features, including predicted internal ribosome entry site structure, a truncated VP4 capsid protein lacking N-terminal myristoylation, a carboxyl-terminal pX extension of VP1, VP2 late domains involved in membrane envelopment, and a cis-acting replication element within the 3D(pol) sequence. Antibodies in some bat sera immunoprecipitated and neutralized human HAV, suggesting conservation of critical antigenic determinants. Limited phylogenetic cosegregation among hepatoviruses and their hosts and recombination patterns are indicative of major hepatovirus host shifts in the past. Ancestral state reconstructions suggest a Hepatovirus origin in small insectivorous mammals and a rodent origin of human HAV. Patterns of infection in small mammals mimicked those of human HAV in hepatotropism, fecal shedding, acute nature, and extinction of the virus in a closed host population. The evolutionary conservation of hepatovirus structure and pathogenesis provide novel insight into the origins of HAV and highlight the utility of analyzing animal reservoirs for risk assessment of emerging viruses.

Indexed as

Biological EvolutionAnimalsHepatitis A virusHumansMammalsMolecular Sequence DataPhylogenyhepatitis A viruspathogenesissmall mammalsviral evolutionzoonosis

Identifiers

PMID26575627
PMCPMC4679062
OpenAlexW2258193335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.